Vaccine China 2011

  • 14-15 Apr 2011
  • New Otani Chang Fu Gong Hotel, Beijing, China

Description

With 1.3 billion inhabitants and over 17 million newborns annually, China is the world largest vaccine consumer and manufacturer. The current vaccine market in China was valued in 2009 to be around $700 million with a annual growth rate expected to increase from around 15% now to 25% over the nex few years, thanks to recently announced government healthcare reforms that aims to bring wider insurance coverage to the population and the emergings of vaccine preventable health threats such as pandemic influenza.

Attracted by its huge potential, investors and biopharmaceuticals from home and abroad are piling into China to strive for market shares to secure long term growth.

However, China s vaccine industry is still in its infancy considering its immature regulatory regime for vaccine industrialization and IPR protection, poor R&D and production engineering capabilities for vaccine development.

Bringing gather regulators, local and international vaccine manufacturers, biotechs, NGOs, technology providers and investors, the Vaccine China 2011 will be probing into the dynamics of China s vaccine industry from various perspectives and discussing best business strategies in expanding and accessing China s vaccine markets.

Past Events

Important

Please, check "Vaccine China" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Immunology, Pharma
Technology: Biotechnology

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions